A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer.

A pilot study was undertaken in eight patients to assess the feasibility of recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) support to intensify standard chemotherapy for advanced ovarian cancer using a shortened 15 day treatment interval. Only four patients completed...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kehoe, S., Poole, C. J., Stanley, A., Earl, H. M., Blackledge, G. R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1994
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968837/
https://ncbi.nlm.nih.gov/pubmed/8123484
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky